![FGO FGO](https://data.pdbj.org/pdbjplus/data/cc/svg/FGO.svg) | FGO | Name: | [(1S,3R,3aR,6aS)-3-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-5,5-bis(oxidanyl)-1,3,3a,4,6,6a-hexahydrocyclopenta[c]furan-1-yl]methyl [(2R,3S,4R,5R)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl] hydrogen phosphate | Formula: | C22 H28 N7 O13 P | SMILES: | NC1=Nc2n(cnc2C(=O)N1)[CH]3O[CH](CO[P](O)(=O)O[CH]4[CH](O)[CH](O[CH]4CO)N5C=CC(=O)NC5=O)[CH]6CC(O)(O)C[CH]36 | InChi: | InChI=1S/C22H28N7O13P/c23-20-26-16-13(17(33)27-20)24-7-29(16)18-9-4-22(35,36)3-8(9)11(41-18)6-39-43(37,38)42-15-10(5-30)40-19(14(15)32)28-2-1-12(31)25-21(28)34/h1-2,7-11,14-15,18-19,30,32,35-36H,3-6H2,(H,37,38)(H,25,31,34)(H3,23,26,27,33)/t8-,9+,10+,11+,14+,15+,18+,19+/m0/s1 | Definition date: | 2020-05-12 | Last modified: | 2021-03-05 | Release date: | 2021-03-10 | Identifier: | [(1~{S},3~{R},3~{a}~{R},6~{a}~{S})-3-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-5,5-bis(oxidanyl)-1,3,3~{a},4,6,6~{a}-hexahydrocyclopenta[c]furan-1-yl]methyl [(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl] hydrogen phosphate |
|
![HNX HNX](https://data.pdbj.org/pdbjplus/data/cc/svg/HNX.svg) | HNX | Name: | (2~{S})-2-azanyl-7-(naphthalen-1-ylmethoxy)-3,4-dihydro-1~{H}-naphthalene-2-carboxylic acid | Formula: | C22 H21 N O3 | SMILES: | N[C]1(CCc2ccc(OCc3cccc4ccccc34)cc2C1)C(O)=O | InChi: | InChI=1S/C22H21NO3/c23-22(21(24)25)11-10-15-8-9-19(12-18(15)13-22)26-14-17-6-3-5-16-4-1-2-7-20(16)17/h1-9,12H,10-11,13-14,23H2,(H,24,25)/t22-/m0/s1 | Definition date: | 2021-01-22 | Last modified: | 2021-03-05 | Release date: | 2021-03-10 | Identifier: | (2~{S})-2-azanyl-7-(naphthalen-1-ylmethoxy)-3,4-dihydro-1~{H}-naphthalene-2-carboxylic acid |
|
![HO0 HO0](https://data.pdbj.org/pdbjplus/data/cc/svg/HO0.svg) | HO0 | Name: | (2~{S})-2-azanyl-7-[(2-phenylphenyl)methoxy]-3,4-dihydro-1~{H}-naphthalene-2-carboxylic acid | Formula: | C24 H23 N O3 | SMILES: | N[C]1(CCc2ccc(OCc3ccccc3c4ccccc4)cc2C1)C(O)=O | InChi: | InChI=1S/C24H23NO3/c25-24(23(26)27)13-12-17-10-11-21(14-20(17)15-24)28-16-19-8-4-5-9-22(19)18-6-2-1-3-7-18/h1-11,14H,12-13,15-16,25H2,(H,26,27)/t24-/m0/s1 | Definition date: | 2021-01-22 | Last modified: | 2021-03-05 | Release date: | 2021-03-10 | Identifier: | (2~{S})-2-azanyl-7-[(2-phenylphenyl)methoxy]-3,4-dihydro-1~{H}-naphthalene-2-carboxylic acid |
|
![HO9 HO9](https://data.pdbj.org/pdbjplus/data/cc/svg/HO9.svg) | HO9 | Name: | (2~{S})-2-azanyl-7-[[2-(1,3-benzoxazol-2-yl)phenyl]methoxy]-3,4-dihydro-1~{H}-naphthalene-2-carboxylic acid | Formula: | C25 H22 N2 O4 | SMILES: | N[C]1(CCc2ccc(OCc3ccccc3c4oc5ccccc5n4)cc2C1)C(O)=O | InChi: | InChI=1S/C25H22N2O4/c26-25(24(28)29)12-11-16-9-10-19(13-18(16)14-25)30-15-17-5-1-2-6-20(17)23-27-21-7-3-4-8-22(21)31-23/h1-10,13H,11-12,14-15,26H2,(H,28,29)/t25-/m0/s1 | Definition date: | 2021-01-22 | Last modified: | 2021-03-05 | Release date: | 2021-03-10 | Identifier: | (2~{S})-2-azanyl-7-[[2-(1,3-benzoxazol-2-yl)phenyl]methoxy]-3,4-dihydro-1~{H}-naphthalene-2-carboxylic acid |
|
![H3C H3C](https://data.pdbj.org/pdbjplus/data/cc/svg/H3C.svg) | H3C | Name: | N-[3-[(4S)-2-azanyl-4-methyl-1,3-thiazin-4-yl]-4-fluoranyl-phenyl]-5-cyano-pyridine-2-carboxamide | Formula: | C18 H14 F N5 O S | SMILES: | C[C]1(C=CSC(=N1)N)c2cc(NC(=O)c3ccc(cn3)C#N)ccc2F | InChi: | InChI=1S/C18H14FN5OS/c1-18(6-7-26-17(21)24-18)13-8-12(3-4-14(13)19)23-16(25)15-5-2-11(9-20)10-22-15/h2-8,10H,1H3,(H2,21,24)(H,23,25)/t18-/m0/s1 | Definition date: | 2020-10-29 | Last modified: | 2021-03-05 | Release date: | 2021-03-10 | Identifier: | ~{N}-[3-[(4~{S})-2-azanyl-4-methyl-1,3-thiazin-4-yl]-4-fluoranyl-phenyl]-5-cyano-pyridine-2-carboxamide |
|
![K4Q K4Q](https://data.pdbj.org/pdbjplus/data/cc/svg/K4Q.svg) | K4Q | Name: | [(2~{S})-2-azanyl-3-oxidanylidene-propyl] octanoate | Formula: | C11 H21 N O3 | SMILES: | CCCCCCCC(=O)OC[CH](N)C=O | InChi: | InChI=1S/C11H21NO3/c1-2-3-4-5-6-7-11(14)15-9-10(12)8-13/h8,10H,2-7,9,12H2,1H3/t10-/m1/s1 | Definition date: | 2019-04-24 | Last modified: | 2021-03-05 | Release date: | 2021-03-10 | Identifier: | [(2~{S})-2-azanyl-3-oxidanylidene-propyl] octanoate |
|
![EZF EZF](https://data.pdbj.org/pdbjplus/data/cc/svg/EZF.svg) | EZF | Name: | methyl 4-[[4-[[3-[4-(aminomethyl)phenyl]-2-methyl-7-oxidanylidene-pyrazolo[4,3-d]pyrimidin-6-yl]methyl]-4-oxidanyl-piperidin-1-yl]methyl]-3-chloranyl-benzoate | Formula: | C28 H31 Cl N6 O4 | SMILES: | COC(=O)c1ccc(CN2CCC(O)(CC2)CN3C=Nc4c(nn(C)c4c5ccc(CN)cc5)C3=O)c(Cl)c1 | InChi: | InChI=1S/C28H31ClN6O4/c1-33-25(19-5-3-18(14-30)4-6-19)23-24(32-33)26(36)35(17-31-23)16-28(38)9-11-34(12-10-28)15-21-8-7-20(13-22(21)29)27(37)39-2/h3-8,13,17,38H,9-12,14-16,30H2,1-2H3 | Definition date: | 2020-02-27 | Last modified: | 2021-03-05 | Release date: | 2021-03-10 | Identifier: | methyl 4-[[4-[[3-[4-(aminomethyl)phenyl]-2-methyl-7-oxidanylidene-pyrazolo[4,3-d]pyrimidin-6-yl]methyl]-4-oxidanyl-piperidin-1-yl]methyl]-3-chloranyl-benzoate |
|
![NJX NJX](https://data.pdbj.org/pdbjplus/data/cc/svg/NJX.svg) | NJX | Name: | 1,5-dimethyl-6-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-3-(3-trimethylsilylprop-2-ynyl)quinazoline-2,4-dione | Formula: | C23 H26 N2 O5 Si | SMILES: | CN1C(=O)N(CC#C[Si](C)(C)C)C(=O)c2c(C)c(ccc12)C(=O)C3=C(O)CCCC3=O | InChi: | InChI=1S/C23H26N2O5Si/c1-14-15(21(28)20-17(26)8-6-9-18(20)27)10-11-16-19(14)22(29)25(23(30)24(16)2)12-7-13-31(3,4)5/h10-11,26H,6,8-9,12H2,1-5H3 | Definition date: | 2020-03-19 | Last modified: | 2021-03-05 | Release date: | 2021-03-10 | Identifier: | 1,5-dimethyl-6-(2-oxidanyl-6-oxidanylidene-cyclohexen-1-yl)carbonyl-3-(3-trimethylsilylprop-2-ynyl)quinazoline-2,4-dione |
|
![18Y 18Y](https://data.pdbj.org/pdbjplus/data/cc/svg/18Y.svg) | 18Y | Name: | Trioxacarcin A analogue, bound form | Formula: | C33 H40 O14 | SMILES: | O=C(C)C1(O)C(O)CC(OC1C)OC57Oc2c(c(cc4c2c(O)c3C(=O)CCCc3c4OC)C)C6OC(OC56)(C(OC)OC)C7(O)C | InChi: | InChI=1S/C33H40O14/c1-13-11-17-23(24(37)22-16(25(17)40-5)9-8-10-18(22)35)26-21(13)27-28-32(45-26,30(4,38)33(46-27,47-28)29(41-6)42-7)44-20-12-19(36)31(39,14(2)34)15(3)43-20/h11,15,19-20,27-29,36-39H,8-10,12H2,1-7H3/t15-,19+,20-,27-,28-,30-,31+,32+,33-/m0/s1 | Synonyms: | (1S,2R,3aS,4S,13aS)-2-(dimethoxymethyl)-1,12-dihydroxy-7-methoxy-1,5-dimethyl-11-oxo-1,2,3a,4,8,9,10,11-octahydro-13aH-2,4-epoxyfuro[3,2-b]naphtho[2,3-h]chromen-13a-yl 4-C-acetyl-2,6-dideoxy-alpha-L-xylo-hexopyranoside | Definition date: | 2012-11-08 | Last modified: | 2021-03-03 | Release date: | 2013-10-23 | Identifier: | (1S,2R,3aS,4S,13aS)-2-(dimethoxymethyl)-1,12-dihydroxy-7-methoxy-1,5-dimethyl-11-oxo-1,2,3a,4,8,9,10,11-octahydro-13aH-2,4-epoxyfuro[3,2-b]naphtho[2,3-h]chromen-13a-yl 4-C-acetyl-2,6-dideoxy-alpha-L-xylo-hexopyranoside |
|
![10M 10M](https://data.pdbj.org/pdbjplus/data/cc/svg/10M.svg) | 10M | Name: | decyl 4-O-alpha-D-glucopyranosyl-1-thio-beta-D-glucopyranoside | Formula: | C22 H42 O10 S | SMILES: | S(CCCCCCCCCC)C2OC(C(OC1OC(CO)C(O)C(O)C1O)C(O)C2O)CO | InChi: | InChI=1S/C22H42O10S/c1-2-3-4-5-6-7-8-9-10-33-22-19(29)17(27)20(14(12-24)31-22)32-21-18(28)16(26)15(25)13(11-23)30-21/h13-29H,2-12H2,1H3/t13-,14-,15-,16+,17-,18-,19-,20-,21-,22+/m1/s1 | Synonyms: | (2R,3R,4S,5S,6R)-2-((2R,3S,4R,5R,6S)-6-Decylsulfanyl-4,5-dihydroxy-2-hydroxymethyl-tetrahydro-pyran-3-yloxy)-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol, n-Decyl-beta-D-thiomaltoside | Definition date: | 2008-02-07 | Last modified: | 2021-03-03 | Identifier: | decyl 4-O-alpha-D-glucopyranosyl-1-thio-beta-D-glucopyranoside |
|
![46D 46D](https://data.pdbj.org/pdbjplus/data/cc/svg/46D.svg) | 46D | Name: | (4AR,6R,7S,8R,8AR)-8-((5R,6R)-3-CARBOXY-TETRAHYDRO-4,5,6-TRIHYDROXY-2H-PYRAN-2-YLOXY)-HEXAHYDRO-6,7-DIHYDROXY-2-METHYLPYRANO[3,2-D][1,3]DIOXINE-2-CARBOXYLIC ACID) | Formula: | C15 H22 O14 | SMILES: | O=C(O)C3OC(O)C(O)C(O)C3OC1OC2COC(OC2C(O)C1O)(C(=O)O)C | InChi: | InChI=1S/C15H22O14/c1-15(14(23)24)25-2-3-8(29-15)5(17)7(19)13(26-3)28-9-4(16)6(18)12(22)27-10(9)11(20)21/h3-10,12-13,16-19,22H,2H2,1H3,(H,20,21)(H,23,24)/t3-,4-,5-,6-,7+,8-,9+,10+,12?,13+,15+/m1/s1 | Synonyms: | 4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE-(1-> | Definition date: | 2005-04-11 | Last modified: | 2021-03-03 | Identifier: | 4-O-{4,6-O-[(1S)-1-carboxyethylidene]-beta-D-mannopyranosyl}-beta-D-glucopyranuronic acid |
|
![48Z 48Z](https://data.pdbj.org/pdbjplus/data/cc/svg/48Z.svg) | 48Z | Name: | 2-deoxy-2-fluoro-5-O-thiophosphono-alpha-D-arabinofuranose | Formula: | C5 H10 F O6 P S | SMILES: | FC1C(O)C(OC1O)COP(=O)(O)S | InChi: | InChI=1S/C5H10FO6PS/c6-3-4(7)2(12-5(3)8)1-11-13(9,10)14/h2-5,7-8H,1H2,(H2,9,10,14)/t2-,3+,4-,5+/m1/s1 | Definition date: | 2011-05-11 | Last modified: | 2021-03-03 | Identifier: | 2-deoxy-2-fluoro-5-O-thiophosphono-alpha-D-arabinofuranose |
|
![ZU3 ZU3](https://data.pdbj.org/pdbjplus/data/cc/svg/ZU3.svg) | ZU3 | Name: | N-[(benzyloxy)carbonyl]-3-[(2,2-dimethylpropanoyl)amino]-L-alanyl-N-[(1R)-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}pentyl]-L-leucinamide | Formula: | C32 H49 N5 O7 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NC(C(=O)NC(CC2C(=O)NCC2)CCC(=O)C)CC(C)C)CNC(=O)C(C)(C)C | InChi: | InChI=1S/C32H49N5O7/c1-20(2)16-25(28(40)35-24(13-12-21(3)38)17-23-14-15-33-27(23)39)36-29(41)26(18-34-30(42)32(4,5)6)37-31(43)44-19-22-10-8-7-9-11-22/h7-11,20,23-26H,12-19H2,1-6H3,(H,33,39)(H,34,42)(H,35,40)(H,36,41)(H,37,43)/t23-,24+,25-,26-/m0/s1 | Synonyms: | TG-0204998 | Definition date: | 2008-10-30 | Last modified: | 2021-03-01 | Identifier: | N-[(benzyloxy)carbonyl]-3-[(2,2-dimethylpropanoyl)amino]-L-alanyl-N-{(2R)-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]hexan-2-yl}-L-leucinamide |
|
![R07 R07](https://data.pdbj.org/pdbjplus/data/cc/svg/R07.svg) | R07 | Name: | 1-[(11S)-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-5-hydroxy-3-[(2R)-1,1,1-trifluoropropan-2-yl]-2,3-dihydro-1H-pyrido[2,1-f][1,2,4]triazine-4,6-dione | Formula: | C24 H20 F3 N3 O3 S | SMILES: | C1(=O)C=CN5C(=C1O)C(=O)N(CN5C3c2ccccc2SCc4c3cccc4)C(C(F)(F)F)C | InChi: | InChI=1S/C24H20F3N3O3S/c1-14(24(25,26)27)28-13-30(29-11-10-18(31)22(32)21(29)23(28)33)20-16-7-3-2-6-15(16)12-34-19-9-5-4-8-17(19)20/h2-11,14,20,32H,12-13H2,1H3/t14-,20+/m1/s1 | Synonyms: | RO-7 | Definition date: | 2017-05-11 | Last modified: | 2021-03-01 | Release date: | 2018-04-11 | Identifier: | 1-[(11S)-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-5-hydroxy-3-[(2R)-1,1,1-trifluoropropan-2-yl]-2,3-dihydro-1H-pyrido[2,1-f][1,2,4]triazine-4,6-dione |
|
![ZU5 ZU5](https://data.pdbj.org/pdbjplus/data/cc/svg/ZU5.svg) | ZU5 | Name: | N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-[(1R)-4-cyclopropyl-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}butyl]-L-leucinamide | Formula: | C34 H52 N4 O7 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NC(C(=O)NC(CC2C(=O)NCC2)CCC(=O)C3CC3)CC(C)C)C(OC(C)(C)C)C | InChi: | InChI=1S/C34H52N4O7/c1-21(2)18-27(31(41)36-26(14-15-28(39)24-12-13-24)19-25-16-17-35-30(25)40)37-32(42)29(22(3)45-34(4,5)6)38-33(43)44-20-23-10-8-7-9-11-23/h7-11,21-22,24-27,29H,12-20H2,1-6H3,(H,35,40)(H,36,41)(H,37,42)(H,38,43)/t22-,25+,26-,27+,29+/m1/s1 | Synonyms: | TG-0205486 | Definition date: | 2008-12-10 | Last modified: | 2021-03-01 | Identifier: | N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-{(2R)-5-cyclopropyl-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-leucinamide |
|
![V2H V2H](https://data.pdbj.org/pdbjplus/data/cc/svg/V2H.svg) | V2H | Name: | (1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol | Formula: | C28 H44 O2 | SMILES: | OC3C(=C)/C(=CC=C1/CCCC2(C)C(C(/C=C/C(C)C(C)C)C)CCC12)CC(O)C3 | InChi: | InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1 | Synonyms: | 1-alpha-hydroxy-vitamin D2 | Definition date: | 2008-07-02 | Last modified: | 2021-03-01 | Identifier: | (1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol |
|
![R0B R0B](https://data.pdbj.org/pdbjplus/data/cc/svg/R0B.svg) | R0B | Name: | (2~{R})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-5-butyl-2,3-dihydro-1,3-thiazole-4-carboxylic acid | Formula: | C12 H19 N O5 S | SMILES: | CCCCC1=C(N[CH](S1)[CH]([CH](C)O)C(O)=O)C(O)=O | InChi: | InChI=1S/C12H19NO5S/c1-3-4-5-7-9(12(17)18)13-10(19-7)8(6(2)14)11(15)16/h6,8,10,13-14H,3-5H2,1-2H3,(H,15,16)(H,17,18)/t6-,8-,10-/m1/s1 | Synonyms: | hydrolyzed faropenem (ring-open form) | Definition date: | 2020-08-24 | Last modified: | 2021-03-01 | Release date: | 2021-02-24 | Identifier: | (2~{R})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-5-butyl-2,3-dihydro-1,3-thiazole-4-carboxylic acid |
|
![UMQ UMQ](https://data.pdbj.org/pdbjplus/data/cc/svg/UMQ.svg) | UMQ | Name: | UNDECYL-MALTOSIDE | Formula: | C23 H44 O11 | SMILES: | O(CCCCCCCCCCC)C2OC(C(OC1OC(CO)C(O)C(O)C1O)C(O)C2O)CO | InChi: | InChI=1S/C23H44O11/c1-2-3-4-5-6-7-8-9-10-11-31-22-20(30)18(28)21(15(13-25)33-22)34-23-19(29)17(27)16(26)14(12-24)32-23/h14-30H,2-13H2,1H3/t14-,15-,16-,17+,18-,19-,20-,21-,22-,23-/m1/s1 | Synonyms: | UNDECYL-BETA-D-MALTOPYRANOSIDE | Definition date: | 2002-09-09 | Last modified: | 2021-03-01 | Identifier: | undecyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside |
|
![TUX TUX](https://data.pdbj.org/pdbjplus/data/cc/svg/TUX.svg) | TUX | Name: | 1,5-ANHYDRO-2-C-(CARBOXYMETHYL-N-HYDROXYAMIDE)-2-DEOXY-3-O-MYRISTOYL-D-GLUCITOL | Formula: | C22 H41 N O7 | SMILES: | O=C(NO)CC1C(OC(=O)CCCCCCCCCCCCC)C(O)C(OC1)CO | InChi: | InChI=1S/C22H41NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-20(26)30-22-17(14-19(25)23-28)16-29-18(15-24)21(22)27/h17-18,21-22,24,27-28H,2-16H2,1H3,(H,23,25)/t17-,18+,21+,22+/m0/s1 | Synonyms: | TU-514 | Definition date: | 2003-03-18 | Last modified: | 2021-03-01 | Identifier: | 1,5-anhydro-2-deoxy-2-[2-(hydroxyamino)-2-oxoethyl]-3-O-tetradecanoyl-D-glucitol |
|
![S80 S80](https://data.pdbj.org/pdbjplus/data/cc/svg/S80.svg) | S80 | Name: | N1-HYDROXY-2-(3-HYDROXY-PROPYL)-3-ISOBUTYL-N4-[1-(2-METHOXY-ETHYL)-2-OXO-AZEPAN-3-YL]-SUCCINAMIDE | Formula: | C20 H37 N3 O6 | SMILES: | O=C(NO)C(CCCO)C(C(=O)NC1C(=O)N(CCOC)CCCC1)CC(C)C | InChi: | InChI=1S/C20H37N3O6/c1-14(2)13-16(15(7-6-11-24)19(26)22-28)18(25)21-17-8-4-5-9-23(20(17)27)10-12-29-3/h14-17,24,28H,4-13H2,1-3H3,(H,21,25)(H,22,26)/t15-,16+,17-/m0/s1 | Synonyms: | A DISUBSTITUTED SUCCINYL CAPROLACTAM HYDROXYMATE MMP3 INHIBITOR | Definition date: | 1999-07-08 | Last modified: | 2021-03-01 | Identifier: | (2S,3R)-N~1~-hydroxy-2-(3-hydroxypropyl)-N~4~-[(3S)-1-(2-methoxyethyl)-2-oxoazepan-3-yl]-3-(2-methylpropyl)butanediamide |
|
![TGL TGL](https://data.pdbj.org/pdbjplus/data/cc/svg/TGL.svg) | TGL | Name: | TRISTEAROYLGLYCEROL | Formula: | C57 H110 O6 | SMILES: | O=C(OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCCC | InChi: | InChI=1S/C57H110O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-55(58)61-52-54(63-57(60)51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)53-62-56(59)50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h54H,4-53H2,1-3H3 | Synonyms: | TRIACYLGLYCEROL | Definition date: | 2003-12-02 | Last modified: | 2021-03-01 | Identifier: | propane-1,2,3-triyl trioctadecanoate |
|
![T22 T22](https://data.pdbj.org/pdbjplus/data/cc/svg/T22.svg) | T22 | Name: | 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile | Formula: | C18 H21 N5 O2 | SMILES: | N#Cc1ccccc1CN2C(=O)N(C(=O)C=C2N3CCCC(N)C3)C | InChi: | InChI=1S/C18H21N5O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3/t15-/m1/s1 | Synonyms: | Alogliptin | Definition date: | 2009-02-03 | Last modified: | 2021-03-01 | Identifier: | 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile |
|
![REK REK](https://data.pdbj.org/pdbjplus/data/cc/svg/REK.svg) | REK | Name: | D-Aspartate Tenofovir | Formula: | C13 H19 N6 O7 P | SMILES: | C[CH](Cn1cnc2c(N)ncnc12)OC[P](O)(=O)N[CH](CC(O)=O)C(O)=O | InChi: | InChI=1S/C13H19N6O7P/c1-7(3-19-5-17-10-11(14)15-4-16-12(10)19)26-6-27(24,25)18-8(13(22)23)2-9(20)21/h4-5,7-8H,2-3,6H2,1H3,(H,20,21)(H,22,23)(H2,14,15,16)(H2,18,24,25)/t7-,8-/m1/s1 | Synonyms: | (2~{R})-2-[[[(2~{R})-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-oxidanyl-phosphoryl]amino]butanedioic acid | Definition date: | 2020-09-28 | Last modified: | 2021-03-01 | Release date: | 2021-01-13 | Identifier: | (2~{R})-2-[[[(2~{R})-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-oxidanyl-phosphoryl]amino]butanedioic acid |
|
![NPX NPX](https://data.pdbj.org/pdbjplus/data/cc/svg/NPX.svg) | NPX | Name: | (2R)-2-(6-methoxynaphthalen-2-yl)propanoic acid | Formula: | C14 H14 O3 | SMILES: | O=C(O)C(c1ccc2c(c1)ccc(OC)c2)C | InChi: | InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m1/s1 | Synonyms: | (R)-Naproxen | Definition date: | 2007-10-04 | Last modified: | 2021-03-01 | Identifier: | (2R)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
|
![XT1 XT1](https://data.pdbj.org/pdbjplus/data/cc/svg/XT1.svg) | XT1 | Name: | (2R)-3-[(2S,5R,6R,8S)-8-{(1R,2E)-3-[(2R,4a'R,5R,6'S,8'R,8a'S)-6'-{(1S,3S)-3-[(2S,3R,6R,11R)-3,11-dimethyl-1,7-dioxaspiro[5.5]undec-2-yl]-1-hydroxybutyl}-8'-hydroxy-7'-methylideneoctahydro-3H,3'H-spiro[furan-2,2'-pyrano[3,2-b]pyran]-5-yl]-1-methylprop-2-en-1-yl}-5-hydroxy-10-methyl-1,7-dioxaspiro[5.5]undec-10-en-2-yl]-2-hydroxy-2-methylpropanoic acid | Formula: | C45 H70 O13 | SMILES: | O=C(O)C(O)(C)CC7OC1(OC(CC(=C1)C)C(/C=C/C6OC2(OC3C(O)C(=C)C(OC3CC2)C(O)CC(C)C5OC4(OCCCC4C)CCC5C)CC6)C)C(O)CC7 | InChi: | InChI=1S/C45H70O13/c1-25-21-35(56-45(23-25)36(47)13-12-32(55-45)24-42(7,51)41(49)50)26(2)10-11-31-15-17-43(54-31)18-16-34-40(57-43)37(48)30(6)39(53-34)33(46)22-28(4)38-27(3)14-19-44(58-38)29(5)9-8-20-52-44/h10-11,23,26-29,31-40,46-48,51H,6,8-9,12-22,24H2,1-5,7H3,(H,49,50)/b11-10+/t26-,27-,28+,29-,31+,32+,33+,34-,35+,36-,37-,38+,39+,40-,42-,43-,44-,45-/m1/s1 | Synonyms: | DINOPHYSISTOXIN-1 | Definition date: | 2009-10-22 | Last modified: | 2021-03-01 | Identifier: | (2R)-3-[(2S,5R,6R,8S)-8-{(2R,3E)-4-[(2R,4a'R,5R,6'S,8'R,8a'S)-6'-{(1S,3S)-3-[(2S,3R,6R,11R)-3,11-dimethyl-1,7-dioxaspiro[5.5]undec-2-yl]-1-hydroxybutyl}-8'-hydroxy-7'-methylideneoctahydro-3H,3'H-spiro[furan-2,2'-pyrano[3,2-b]pyran]-5-yl]but-3-en-2-yl}-5-hydroxy-10-methyl-1,7-dioxaspiro[5.5]undec-10-en-2-yl]-2-hydroxy-2-methylpropanoic acid |
|